Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of antineoplaston therapy in low-grade non-Hodgkin's lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Non-hodgkin Lymphoma

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Low-Grade Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2019-04-16